Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTEGRA
NCT04804072Completed
- Sponsor
- HIV Prevention Trials Network
- Start
- Jun 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by HIV Prevention Trials Network. Primary endpoints: Documented Current Use of MOUD at 26 weeks and Documented Current Use of PrEP at 26 weeks. Started Jun 2021; status: completed.
Beyond the preview
Go deeper on NCT04804072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804072.